Breaking News Instant updates and real-time market news.

TGTX

TG Therapeutics

$8.25

-0.64 (-7.20%)

10:44
10/13/16
10/13
10:44
10/13/16
10:44

Roth Capital remains a buyer of TG Therapeutics after GENUINE announcement

After TG Therapeutics announced that it amended the Phase 3 GENUINE study to have overall response rate as the primary endpoint, Roth Capital analyst Joseph Pantginis says the company is making the hard but right decision. While perceptions are negative on trial amendments, the analyst believes this clarity on timelines, the robustness of Phase 2 data and important drug approval precedents continue to point to a positive outcome for the study. Pantginis believes TG Therapeutics' shares are being oversold, and reiterates a Buy rating and $33 price target on the stock. In late morning trading, shares of TG Therapeutics have dropped more than 14% to $7.07.

  • 13

    Oct

TGTX TG Therapeutics
$8.25

-0.64 (-7.20%)

12/07/15
ROTH
12/07/15
NO CHANGE
Target $33
ROTH
Buy
TG Therapeutics gave 'strong' update at ASH, says Roth Capital
Roth Capital analyst Joseph Pantginis said TG Therapeutics' update at the ASH meeting was "strong" and that he continues to be impressed by both the efficacy and safety profile of the company's two lead drugs. The analyst keeps a Buy rating and $33 price target on the stock, which is a Focus Pick of the firm.
04/18/16
ROTH
04/18/16
NO CHANGE
Target $33
ROTH
Buy
TG Therapeutics remains Focus Pick at Roth Capital
Roth Capital analyst Joseph Pantginis says TG Therapeutics (TGTX) remains a Focus Pick, and reiterates a Buy rating and $33 price target on the company's shares. The analyst believes the accumulated data set and late stage aspect of the platform has de-risked the outcomes of the Phase 3studies for TG Therapeutics' TG-1101 and TGR-1202. Besides TG Therapeutics, Strongbridge (SBBP), Ligand (LGND), Concert (CNCE) and Cerulean (CERU) also fit into the "de-risked" category in the healthcare universe, Pantginis tells investors in a research note.
05/27/16
RHCO
05/27/16
INITIATION
Target $18
RHCO
Buy
TG Therapeutics initiated with a Buy at SunTrust
SunTrust analyst Yatin Suneja initiated TG Therapeutics with a Buy rating and $18 price target.
10/06/16
BMUR
10/06/16
INITIATION
Target $28
BMUR
Buy
TG Therapeutics assumed coverage with a Buy at Brean Capital
Brean Capital analyst Jason Wittes assumed coverage on TG Therapeutics with a Buy and $28 price target.

TODAY'S FREE FLY STORIES

RES

RPC, Inc.

$17.90

0.35 (1.99%)

07:56
04/26/17
04/26
07:56
04/26/17
07:56
Earnings
RPC, Inc. reports Q1 EPS 2c, consensus (4c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

SAJA

Sajan

$3.99

0.19 (5.00%)

07:55
04/26/17
04/26
07:55
04/26/17
07:55
Hot Stocks
Breaking Hot Stocks news story on Sajan »

Sajan trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LB

Labarge

$50.60

-0.09 (-0.18%)

07:54
04/26/17
04/26
07:54
04/26/17
07:54
Upgrade
Labarge rating change  »

L Brands upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOKF

BOK Financial

$80.29

0.69 (0.87%)

07:54
04/26/17
04/26
07:54
04/26/17
07:54
Earnings
BOK Financial reports Q1 EPS $1.35, consensus $1.05 »

Steven G. Bradshaw,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

VIAB

Viacom

$42.95

0.2 (0.47%)

07:53
04/26/17
04/26
07:53
04/26/17
07:53
Recommendations
Viacom analyst commentary  »

Viacom price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

AAPL

Apple

$144.53

0.89 (0.62%)

, SSNLF

Samsung

07:52
04/26/17
04/26
07:52
04/26/17
07:52
Periodicals
Apple plans to replace OLED with micro-LED in Apple Watch 3, Apple Insider says »

Apple (AAPL) is…

AAPL

Apple

$144.53

0.89 (0.62%)

SSNLF

Samsung

LPL

LG Display

$13.88

0.5 (3.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

GLW

Corning

$28.54

1.02 (3.71%)

, VZ

Verizon

$46.70

-0.35 (-0.74%)

07:52
04/26/17
04/26
07:52
04/26/17
07:52
Recommendations
Corning, Verizon analyst commentary  »

Corning doing better than…

GLW

Corning

$28.54

1.02 (3.71%)

VZ

Verizon

$46.70

-0.35 (-0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

  • 31

    May

  • 16

    Jun

DD

DuPont

$82.21

2.84 (3.58%)

07:51
04/26/17
04/26
07:51
04/26/17
07:51
Recommendations
DuPont analyst commentary  »

DuPont price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 31

    May

SPGI

S&P Global

$135.61

1.71 (1.28%)

07:50
04/26/17
04/26
07:50
04/26/17
07:50
Recommendations
S&P Global analyst commentary  »

S&P Global price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Apr

07:50
04/26/17
04/26
07:50
04/26/17
07:50
General news
N.Y. FX Outlook »

N.Y. FX Outlook: The…

BDX

Becton Dickinson

$179.07

2 (1.13%)

, RHHBY

Roche

$32.41

0.397 (1.24%)

07:49
04/26/17
04/26
07:49
04/26/17
07:49
Hot Stocks
Becton Dickinson licenses novel molecular indexing technology to Roche »

Becton Dickinson (BDX)…

BDX

Becton Dickinson

$179.07

2 (1.13%)

RHHBY

Roche

$32.41

0.397 (1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 07

    May

  • 06

    Jun

  • 26

    Jun

HUM

Humana

$217.97

4.21 (1.97%)

07:49
04/26/17
04/26
07:49
04/26/17
07:49
Recommendations
Humana analyst commentary  »

Humana price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 16

    May

  • 13

    Jun

07:47
04/26/17
04/26
07:47
04/26/17
07:47
General news
Futures little changed as earnings parade marches on »

Stock futures are off…

CAT

Caterpillar

$104.42

7.61 (7.86%)

07:46
04/26/17
04/26
07:46
04/26/17
07:46
Recommendations
Caterpillar analyst commentary  »

Caterpillar price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 14

    Jun

MCD

McDonald's

$141.70

7.47 (5.57%)

07:46
04/26/17
04/26
07:46
04/26/17
07:46
Recommendations
McDonald's analyst commentary  »

McDonald's price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

SAP

SAP

$102.13

0.75 (0.74%)

07:45
04/26/17
04/26
07:45
04/26/17
07:45
Downgrade
SAP rating change  »

SAP downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

FCAU

Fiat Chrysler

$10.54

-0.02 (-0.19%)

07:44
04/26/17
04/26
07:44
04/26/17
07:44
Earnings
Fiat Chrysler confirms FY17 guidance for revenue, EBIT »

The Group confirms…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHI

Baker Hughes

$59.29

0.64 (1.09%)

07:43
04/26/17
04/26
07:43
04/26/17
07:43
Recommendations
Baker Hughes analyst commentary  »

Baker Hughes price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

SYBT

S.Y. Bancorp

$42.30

0.85 (2.05%)

07:43
04/26/17
04/26
07:43
04/26/17
07:43
Earnings
S.Y. Bancorp reports Q1 EPS 47c, consensus 45c »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 03

    May

CBOE

CBOE Holdings

$84.16

0.32 (0.38%)

07:43
04/26/17
04/26
07:43
04/26/17
07:43
Syndicate
CBOE Holdings 2.25M share Block Trade; price range $83.25-$83.75 »

Jefferies is acting as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

FCAU

Fiat Chrysler

$10.54

-0.02 (-0.19%)

07:43
04/26/17
04/26
07:43
04/26/17
07:43
Earnings
Fiat Chrysler reports Q1 adjusted EBIT EU1.54B, consensus EU1.44B »

Reports Q1 revenues of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSS

TSYS

$54.31

0.5 (0.93%)

07:42
04/26/17
04/26
07:42
04/26/17
07:42
Recommendations
TSYS analyst commentary  »

TSYS price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERJ

Embraer

$19.45

-0.3083 (-1.56%)

07:42
04/26/17
04/26
07:42
04/26/17
07:42
Periodicals
Embraer partners with Uber to develop electric vehicles, Reuters reports »

Brazilian planemaker…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLGN

Silgan Holdings

$60.10

0.24 (0.40%)

07:41
04/26/17
04/26
07:41
04/26/17
07:41
Earnings
Silgan Holdings raises FY17 adj. EPS view to $3.20-$3.40 from $3.15-$3.35 »

Silgan Holdings increased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 09

    May

SAH

Sonic Automotive

07:41
04/26/17
04/26
07:41
04/26/17
07:41
Earnings
Sonic Automotive reports Q1 adjusted EPS 23c, consensus 23c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 03

    May

  • 20

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.